Featured Editorial

1. 6 Packaging And Delivery Challenges For Biologic Therapies 4/1/2026

   In this article, Fran DeGrazio identifies six aspects of biologics-based therapy packaging and delivery that, if addressed, may help to ensure successful product development and lifecycle management. They include 1) chemical compatibility with device functionality, 2) long-acting formulations, 3) product stability, 4) primary packaging and device integration, 5) cold storage, and 6) higher concentrations and viscosities. 

2. Beyond Biologics: A Biophysical Approach To Crohn's Disease 4/1/2026

   Research into a nano-amorphous approach suggests a new breakthrough in Crohn’s management may come from a shift toward modulating the biophysical environment of the gut.

3. Does TSLP Inhibition Signal The Next Wave Of Respiratory Biologics? 4/1/2026

   Thymic stromal lymphopoietin (TSLP) inhibition has firmly established itself as a strategy in respiratory disease. This article highlights some promising drug candidates and next-generation approaches.

4. Nanosystems And Rare Diseases: Opportunities And Limitations 3/27/2026

   Nanosystems offer unique capabilities, enabling researchers to design precise, versatile delivery systems that address key challenges in rare diseases.

5. 3 Emerging Trends In Drug Delivery Device Pipelines 3/18/2026

   When analyzing the drug delivery product pipeline, three key technologies stand out. Check out the latest market research.

6. Organic Impurities: New Draft ICH Q3E Guidance For Leachables And Extractables 3/17/2026

   A new draft guidance document from ICH, issued jointly with the EMA, adopts the position that the assessment of leachables and extractables requires a holistic framework for risk evaluation.

7. Closing The Adherence Gap: The Connected Health Era 3/13/2026

   Connected health is shifting healthcare from reactive to proactive by enabling providers to oversee drug delivery while allowing patients to actively engage in their care.

8. Delivery Strategy For Next-Gen Cardiac Gene Therapies 3/12/2026

   As the field matures, the most transformative gene therapies in heart health are treating delivery not as an afterthought but as a fundamental principle.

9. The Future Of Kidney Disease Therapeutics: Bringing Nanomedicine To Nephrology 3/6/2026

   Nanomedicines are solving the drug delivery problem in kidney disease. The next step: bridging the translational gap to advance these technologies into the clinic.

10. Injecting Cancer Killers: Intratumoral Therapy For Solid Tumors 3/5/2026

    Intratumoral injection bypasses the tumor’s physical defenses entirely, killing cancer cells and creating a personalized immune response that destroys solid tumors.